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Abstract
Background: The Migraine Disability Assessment (MIDAS) is a brief questionnaire and measures headache-related
disability. This study aimed to translate and cross-culturally adapt the original English version of the MIDAS to
German and to test its reliability.
Methods: The standardized translation process followed international guidelines. The pre-final version was tested
for clarity and comprehensibility by 34 headache sufferers. Test-retest reliability of the final version was quantified
by 36 headache patients completing the MIDAS twice with an interval of 48 h. Reliability was determined by
intraclass correlation coefficients and internal consistency by Cronbach’s α.
Results: All steps of the translation process were followed, documented and approved by the developer of the
MIDAS. The expert committee discussed in detail the complex phrasing of the questions that refer to one to
another, especially exclusion of headache-days from one item to the next. The German version contains more
active verb sentences and prefers the perfect to the imperfect tense. The MIDAS scales intraclass correlation
coefficients ranged from 0.884 to 0.994 and was 0.991 (95% CI: 0.982–0.995) for the MIDAS total score. Cronbach’s α
for the MIDAS as a whole was 0.69 at test and 0.67 at retest.
Conclusions: The translation process was challenged by the comprehensibility of the questionnaire. The German
version of the MIDAS is a highly reliable instrument for assessing headache related disability with moderate internal
consistency. Provided validity testing of the German MIDAS is successful, it can be recommended for use in clinical
practice as well as in research.
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Background
In the adult population, headache disorders have been re-
ported to be among the 10 most disabling conditions on
the World Health Organization’s ranking of causes of dis-
ability [1]. The total annual cost of headache in adults
aged 18–65 years in the EU was estimated at 173 billion
Euros, reflecting the high individual and societal impact
[2]. Headache disorders have a very high impact on
patients and lead to limitations in daily activities like work
or school, household activities, and social and leisure
activities [3]. Loss of days for work, housework or social
activities due to migraine was more than 10% in 28.0% of
female and 17.7% of male patients [3].
There are several instruments that measure the disease-
specific and health-related disability and its impact on the
quality of life of headache sufferers. The Migraine Disability
Assessment (MIDAS) questionnaire was originally devel-
oped to assess the migraine-related disability of English
speaking patients [4]. This tool is one of the most widely
used questionnaires and measures impact of headache on
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the functioning at work, in school and in social activities by
assessing lost days in the past 3 months [5]. MIDAS ques-
tions are not specific for a type of headache, but ask about
headache in general. This means that the MIDAS can be
used for any types of headaches including acute or chronic
migraine, tension-type headache, episodic headache, and
medication-overuse headache.
It is a short, easy to use and score questionnaire with
7 items. The first 5 questions assess completely lost days
and the days with a reduced productivity of at least 50%,
which add up to give the MIDAS total score. The fre-
quency and intensity of the headaches over the past
3 months are assessed by the last 2 questions. The grad-
ing system of the MIDAS categorises the MIDAS total
score into Grade I to IV, from minimal or infrequent
disability with a score of 0–5 (Grade I) to severe disabil-
ity with a score of 21 or more (Grade IV).
The MIDAS questionnaire is available for use free of
charge and can be used in clinical practice as well as in
research. It was designed to improve patient-doctor com-
munication, to measure headache-related disability, and to
stratify patients by treatment needs [6]. It also meets physi-
cians’ conceptions of important clinical criteria and seems,
therefore, suitable for use in clinical practice [7–9]. All out-
come domains of the MIDAS were considered important
to people with chronic pain and are among the outcome
domains recommended by the Initiative on Methods,
Measurement, and Pain Assessment (IMMPACT) [10].
Reliability and validity of the MIDAS questionnaire have
been tested extensively in numerous studies in various
countries and in different languages [4, 7, 11–20]. A German
version of the MIDAS was published by Agosti et al. in 2008
[21]. This version was linguistically validated by a second
translation by an independent and qualified translator.
However, the steps of forward- and backward-translation
proposed by the cross-cultural adaptation process were not
completely followed [22]. Reliability and validity of this ver-
sion was not tested. So far, no specific self-assessment instru-
ment in German measuring headache-related disability in
patients with migraine has been translated in accordance
with the above-mentioned international guidelines [22].
The first goal of this study was to translate and cross-
culturally adapt the original English version into German
according to the standardized, well-established proced-
ure [22]. The second aim of the study was to describe
the metric properties and to quantify test-retest reliabil-
ity. Further, the full length German version of the
MIDAS questionnaire should be published for free use.
Methods
This study was conducted at the rehabilitation clinic “Reha-
Clinic” in Bad Zurzach, Switzerland. Two samples were re-
cruited, one to test the pre-final version of the German
MIDAS and one for test-retest reliability. Written informed
consent was obtained from all participants in this study.
The study protocol was approved by the Local Ethic Com-
mission (Health Department in Aarau, Switzerland, EK AG
2008/026).
Translation and cross-cultural adaptation
Translation and cross-cultural adaptation was done accord-
ing to the international guidelines of the American Associ-
ation of Orthopedic Surgeons (AAOS) Outcome Committee
and was preliminary discussed and approved by the devel-
oper of the MIDAS, Walter. F. Stewart [22]. This procedure
is based on the original guideline of Guillemin et al. 1993
and has been further developed and illustrated by Beaton et
al. and other authors [22–25]. The translational process de-
scribed in all those studies emphasizes the importance of the
translation process and translation quality in order to
maximize attainment of equivalence. The components of the
process are principally equal in all those studies and are
considered to be exemplary in the fundamental textbook of
Streiner et al. [26]. It consists of the following 6 stages:
1) Forward translation
Two bilingual (fluent in written and spoken German
and English) German native speakers independently
translated the MIDAS from English to German. One
translator was informed about the intention of the
questionnaire and had a medical background. The
second translator did not have any medical
background and was without any prior knowledge of
the purpose and use of the MIDAS. Both
independently delivered a written report.
2) Synthesis of the 2 first German versions
The two written reports were synthesized to one
German version by consensus by the two translators
and recorded by the study nurse.
3) Back translation of the synthesis
The synthesis of the two translations to German was
then independently translated back to English by 2
persons with English as a native language and excellent
German language and culture knowledge. The 2
translators both had a different original cultural
background, one from New Zealand, one from
England.
4) Expert committee review to achieve the pre-final
German version
The expert committee consisted of all the
translators, 1 general practitioner and
epidemiologist, 1 physiotherapist and 1 research
assistant. This committee reviewed the original
version, German versions and the back-translations.
By consensus, the expert committee formulated the
pre-final version by discussing the semantic, idiom-
atic, experiential and conceptual equivalence, made
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the necessary changes and documented the adapta-
tions in a written report.
5) Testing of the pre-final version and adaptation to
the final German version
The pre-final version was tested on n = 34 persons who
all suffered from headache, recruited from December
2014 till March 2015. The majority (n = 26) was
included by convenience sampling of consecutively
admitted patients to the Pain Center of the rehabilita-
tion clinic “RehaClinic” in Bad Zurzach, Switzerland. It
consists of three specific, in-house, multidisciplinary re-
habilitation programs: for medication overuse head-
ache, for whiplash associated disorders, for chronic
musculoskeletal pain disorders. Further, 4 ambulatory
patients from general practice and 2 employees com-
pleted the questionnaire. This sample also covered 2
twelve-year-old teenagers with headache representing
persons with limited education as recommended [22].
All subjects rated clarity and comprehensiveness of the
title, the instructions and the questions on a scale from
0 (=not comprehensible at all) to 10 (=easily compre-
hensible). Furthermore, free comments about what he
or she thought was meant by each questionnaire item
and the chosen response could be added [22]. Further,
time needed to fill out the questionnaire was recorded.
Based on the comments of the pre-test, final adapta-
tions were made by the expert committee [27].
6) Submission and Appraisal of all written reports by
the developer
Each process was documented in a written report
which was approved by the developer of the
questionnaire, W.F. Stewart.
Test-retest reliability testing
Test-retest reliability testing was started after completion
of stage 6 in March 2015 and lasted till September 2015.
Consecutive convenience sampling in the Pain Center of
the rehabilitation clinic “RehaClinic” in Bad Zurzach,
Switzerland was performed to obtain a new sample dif-
ferent from the sample for testing the pre-final version
(n = 36). Of those, n = 33 were recruited at the Pain
Center and n = 3 from general practice, all suffering
from chronic episodic headache. Sample size was preter-
mined. To detect an intraclass correlation coefficient
(ICC) = 0.80 with a power = 80% and type I error = 0.05 a
sample size of n = 36 patients was necessary [28].
All patients were tested twice with a time interval of
48 to 60 h between completed questionnaires. We as-
sumed that 48 h was enough time for patients not to re-
call the results of the first completed questionnaire. By
that, the 2 time windows of 90 days recall were highly
congruent. For reliability testing, the period of 2 days
was considered to be equivalent to that of 2 weeks [29].
The first questionnaire was given to the in-house
patients on Friday and patients were asked to fill out the
questionnaire on Friday evening after the last medical
treatment. The second questionnaire was filled out on
Monday morning before the first treatment. The time
period in between was considered as stable because no
medical treatment was administered.
Analysis
For the pre-test results of clarity and comprehensibility the
mean averages of the different components and the time
needed to complete the questionnaire were calculated. Based
on these average scores and the test persons’ comments, the
pre-final version of the questionnaire was adapted.
Test-retest reliability of the final version was quantified
by the ICC. The ICC quantifies the extent to which the
same test results are obtained for repeated measurements
when no change of results is expected between the two as-
sessments. We calculated the ICC for each question on
the MIDAS (question 1–5 and additional questions A + B)
and the total MIDAS score. For better classification, the
MIDAS total score was transformed into a scale from 0
(no days) to 100 (maximum of 276 days = worst score).
The ICC score ranges from 0.00 indicating no reliabil-
ity to 1.00 indicating perfect reliability. An ICC ≥ 0.80 re-
flects high test-retest reliability and means that 64%
(0.80 squared) of the variance of the test scores are ex-
plained by the retest scores.
The internal consistency of the German version of the
MIDAS total score of items 1–5 was determined by
Cronbach’s alpha (α) at test. A Cronbach’s α of 0.7 is
deemed acceptable and of value of 0.8 is deemed excel-
lent internal consistency. At test assessment, the floor
effect was quantified as the percentage of patients who
achieved the worst possible score and the ceiling effect
as the percentage achieving the best possible score.
The extent of agreement between the first and the sec-
ond measurement was examined with a Bland-Altman
plot [30]. This method plots the difference between the
pairs of the two measurements against the mean of each
pair of measurement. The limits of agreement were cal-
culated as the mean difference +/− twice the standard
deviation [26].
All analyses were performed using the statistical soft-
ware package IBM SPSS 23.0 for Windows® (SPSS Inc.,
Chicago, IL, USA).
Results
Translation and cross-cultural adaptation process
The procedure of stages I – VI as described by Beaton et al.
[22] was planned carefully and realised as required without
deviation from the protocol.
In the instructions for the original questionnaire, the
following phrase was given in brackets: “Please refer to
the calendar below, if necessary.” A calendar was not
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included in the original version. Therefore, this phrase
was excluded in the final version by the expert commit-
tee at stage IV and with the permission of the author of
the original questionnaire (stage VI).
The forward translation resulted in activities which
were expressed in the imperfect (past tense) in German
(stages I – II). Back-translation led to perfect tense in
English in some items (stage III). The expert committee
decided to use the German perfect tense consistently
across all items to reflect activities which have happened
in the last 3 months up to present (stage IV). Perfect
tense and imperfect tense are almost synonymously used
in Germany, but in Swiss German only perfect tense ex-
ists. To clarify, the MIDAS was translated into “German”
German, which is the written and spoken language in
Germany and the written language in Switzerland.
All members of the expert committee rated the in-
struction “do not include days you counted in question
1 where you missed work or school” (item 2) as very dif-
ficult to understand. It was considered very likely that
mistakes in counting the number of days for items 2 and
item 4 might occur because of it. However, the instruc-
tion was translated word for word to stay consistent with
the original version.
Pre-test (stage V)
Clarity and comprehensibility were rated by the 34 per-
sons suffering from headache with an average score of
3.76 for the title, 8.74 for the instructions and 8.5 for the
questions of the MIDAS. For all 34 questionnaires with
a total of 238 items, there were 9 missing items (3.8%).
The average time needed to complete the questionnaire
was 3.62 min. The 2 teenagers did not have any prob-
lems understanding and filling out the questionnaire.
Many respondents stated under comments that sentences
had to be read at least twice to understand the exact con-
tent. For those participants who had headaches during the
rating procedure, concentration was reported to be difficult.
Specifically, some patients were challenged in recalling the
exact number of days in the last 3 months with limitations
due to their headaches. Six of the 34 persons reported diffi-
culties in remembering the number of headache days of the
last 3 months. Seven of the 34 participants found it very dif-
ficult to subtract the number of headache days of the previ-
ous item in items 2 and 4. Patients not working due to
unemployment, retirement or a sick certificate found the
questionnaire to be inapplicable to their situation. However,
these difficulties did not lead to adaptations of the pre-final
version to keep congruence with the original version.
Based on the results of the pre-test, we concluded that
the German version of the MIDAS questionnaire is a
comprehensible questionnaire which can be filled out in
less than 4 min. Adaptation of the title was needed to
make it more comprehensible. The title in the pre-final
version “Der MIDAS Fragebogen” (translated in English:
“the MIDAS questionnaire”) was changed to “Der MIDAS
Fragebogen (Migraine Disability Assessment)” and com-
pleted with an additional explanation of the goal of this
questionnaire: “Fragebogen zur Erfassung der funktionel-
len Einschränkung durch Kopfschmerzen, insbesondere
Migräne” (translated in English: “questionnaire to assess
disability related to headaches, especially migraine”). The
Additional file 1 shows the final German version of the
MIDAS questionnaire.
Reliability testing
Of the total sample (n = 36), mean age was 43.8 (stand-
ard deviation (sd) = 14.5), 27 (75%) patients participated
in the medication overuse headache program, and 30
(83%) were female.
At test (first administration of the MIDAS), the mean
number of days with disability due to headache ranged
from 14.5–22.0 across the items 1–5 (Table 1). The aver-
age number of days with headache (item A) was re-
ported 61.4 days with large variation (sd = 27.3). Pain
severity (item B) was on average 5.86 (sd = 5.87, 10 =
worst pain). The total MIDAS score for items 1–5 aver-
aged to 68.1 (100 = no disability due to headache).
Frequencies of floor scores (worst possible scores, Table 1)
were low: 1 patient on item 1 and the same patient in
question A (number of headache days per 3. months). Fur-
ther, one rated worst pain on the Numeric Rating Scale
(NRS) (Item B). Ceiling phenomena were very frequent in
items 1–5, especially in item 1 (41.7% reported 0 days of
missing work or school because of your headaches in the last
3 months) and least in item 5 (8.3% reported 0 days of miss-
ing family, social or leisure activities because of your head-
aches in the last 3 months). Ceiling on the total MIDAS
score was rated by 2 patients (0 days missing/reduced prod-
uctivity due to the headaches in items 1–5). There was no
ceiling on item As and B.
All 7 items as well as the MIDAS total score showed
an ICC equal to or greater than 0.884 (Table 1). Item B,
the average of pain intensity, was lowest with an ICC of
0.884 whereas item 5, which asked for the lost days in
family, social or leisure activities was 0.994. The MIDAS
total score showed a high ICC of 0.991. The internal
consistency of items 1–5 at test was Cronbach’s α =
0.690 (95% CI 0.495–0.825) and 0.670 (95% CI 0.463–
0.814) at retest.
The Bland-Altman plot (Fig. 1) showed that the mean
difference in the total MIDAS score between the two
measurements was − 0.45 and the 95% limits of agree-
ment were 6.76 and − 7.67. Differences between the first
and second measurements were within the limits of
agreement (mean +/− twice the standard deviation).
There was, however, one clear outlier. The plot indicated
that there was agreement between the measurements
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Table 1 Descriptive (at test) and reliability data for the German MIDAS (n = 36)
Item Wording of the original MIDAS [4] Minimum Maximum Mean SD ICC 95% CI
1 On how many days in the last 3 months did you miss work or school
because of your headaches?
0
(41.7%)
92
(2.8%)
14.47 26.75 0.988 0.976–0.994
2 How many days in the last 3 months was your productivity at work or
school reduced by half or more because of your headaches?
(Do not include days you counted in question 1 where you missed
work or school.)
0
(33.3%)
90
(0.0%)
21.00 27.37 0.962 0.926–0.980
3 On how many days in the last 3 months did you not do household
work (such as housework, home repairs and maintenance, shopping,
caring for children and relatives) because of your headaches?
0
(19.4%)
90
(0.0%)
17.17 21.27 0.989 0.979–0.994
4 How many days in the last 3 months was your productivity in household
work reduced by half or more because of your headaches?
(Do not include days you counted in question 3 where you did not
do household work.)
0
(19.4%)
90
(0.0%)
20.69 23.26 0.896 0.806–0.946
5 On how many days in the last 3 months did you miss family, social
or leisure activities because of your headaches?
0
(8.3%)
90
(0.0%)
22.03 26.87 0.994 0.988–0.997
A On how many days in the last 3 months did you have a headache?
(If a headache lasted more than 1 day, count each day.)
5
(0.0%)
92
(2.8%)
61.44 27.27 0.920 0.849–0.958
B On a scale of 0–10, on average how painful were these headaches?
(where 0 = no pain at all, and 10 = pain as bad as it can be.)
1
(0.0%)
10
(2.8%)
5.86 1.57 0.884 0.785–0.939
Total Score MIDAS
Items 1–5 (276 = worst)
0
(5.6%)
235
(0.0%)
87.97 70.47 0.991 0.982–0.995
Total Score MIDAS
Items 1–5 (0 = worst, 100 = best)
14.86
(0.0%)
100
(5.6%)
68.13 25.53 0.991 0.982–0.995
Legend: The percentages in parentheses in the Minimum and Maximum column indicate the frequencies of floor and ceiling values: minimum: percentage with 0
= ceiling; maximum: percentage with worst possible score = floor; for items 1–5 (92 = worst), A (92 = worst), B (10 = worst) and MIDAS total score (276 = worst). For
MIDAS total score (100 = best) vice versa
MIDAS Migraine Disability Assessment, SD Standard Deviation, ICC Intraclass correlation coefficient, 95% CI: 95% confidence interval for the ICCs
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and that there was no relationship between the differ-
ences and the MIDAS total score. The difference be-
tween the two measurements did not get larger or
smaller with an increased average.
Discussion
We translated and cross-culturally adapted the original
English version of the MIDAS into German and tested its
test-retest-reliability. As a result, the German MIDAS
seems comprehensible and linguistically very close to the
original version and patient responses were highly reliable.
Several problems emerged with the assessment period
and the content of the MIDAS questions based on the
standardized 6 stages of translation and cross-cultural
adaptation. Especially in stage V: cross-sectional testing of
the pre-final version, many persons reported that it was
difficult to accurately recall the number of headache days
within the last 3 months and that the content of some
items is difficult to understand. For example, problems
caused items 2 and 4 where the number of headache days
assessed by the previous item has to be subtracted. These
difficulties of comprehensibility are aggravated if the par-
ticipants have a headache at the time and their concentra-
tion is affected. These problems led to lengthy discussions
in the consensus conference team (stage IV). However,
the phrasing of the final German version is very close to
the original version, which was supported by the agree-
ment of the developer W.F. Stewart. After the title, the
additional phrase highlights that the questionnaire asks
about limitations due to headache. For better comprehen-
sibility, the English imperfect/past tense was changed to
the German perfect tense throughout the questionnaire.
In the development of the original MIDAS, it turned
out that a 90 day recall period did offer a more reliable
assessment of patient’s experience than a 45 day recall
period and that the corresponding numbers of days of
disability due to headache (items 1–5) were similar to
those assessed by a daily headache diary [12].
In reliability testing on 36 persons suffering from
headache, items 1 and 2 showed high and items 3 and 4
moderate ceiling effects, whereas item 5 and the total
score had low ceiling effects. Floor effects were very low
or absent. Although pain levels were moderately high
(on average 5.86) and the mean number of headache
days was two of three months (item A), a high propor-
tion of the participants did not feel disabled to perform
work (items 1 and 2). In the validity study of the original
MIDAS it was shown that affected persons firstly reduce
household chores, social, and leisure activities before
they miss work or school [12].
The test-retest (2 to 2.5 days later) ICC’s of the 7 items
were very high and ranged from 0.884 (item B: pain NRS)
to 0.989 (item 3: disability in household work). All ICC’s
were statistically significant at type I error = 0.05 and a
power of 0.80 (type II error = 0.20). The total MIDAS
score composed of the sum of items 1 to 5 was very highly
reliable (ICC = 0.991), but the 5 items showed moderate
internal consistency (Cronbach’s α = 0.690). This means
that the content of the five items reflects some divergence
in the constructs. For example, retired and unemployed
persons have difficulties rating disability at work or school
(items 1 and 2), in contrast to disability concerning house-
hold work (item 3 and 4), or disability for social activities
(item 5). The original MIDAS aimed to cover all those 3
constructs separately and the relatively low Cronbach’s α
reflects that this strategy was successful [4].
Our high test-retest reliability stays in contrast with the
relatively lower test-retest Spearman correlation of be-
tween 0.46 and 0.78 for items 1 to 5 of the original
MIDAS version in migraine headache sufferers [7]. How-
ever, the original MIDAS showed a good correlation with
physicians’ assessment and a diary-based measurement of
disability [12].
The original MIDAS has been translated into several
languages and the reliability of the Chinese [13], French
[14], Hindi [15], Japanese [16], Malay [17], Persian [18],
Thai [19], and Turkish [20] versions has been tested.
The test-retest Pearson or Spearman correlation coeffi-
cients in the different versions ranged from 0.84 to 0.87
for single items of the MIDAS and from 0.65 to 0.94 for
the MIDAS total score. Cronbach’s α for internal
consistency ranged from 0.65 to 0.84. The results of the
German version of the MIDAS in this study are compar-
able to those reported for the original English as well as
the various translations of the MIDAS.
The standardized process of translation and cross-
cultural adaptation was strictly followed. This is a
strength of this study. The process was characterized by
intensive discussions about the equivalence of the con-
tent and the precise phrasing of the pre-final version in
stage IV. Minor adaptations in the title of the question-
naire improved the comprehensibility. Another strength
of this study is that the number of patients in the pretest
was reached as proposed by Beaton et al. [22]. The sam-
ple size for reliability testing was predefined by sample
size calculation. Test and retest assessments were per-
formed in a period without therapy where the state of
the patient was assumed to be stable.
The selection of patients at an inpatient rehabilitation
clinic from those participating in a program for head-
ache disorders and after withdrawal from medication
overuse may limit the generalizability of the results. Val-
idity testing of the German MIDAS will complete the
psychometric properties of the instrument in future.
Conclusions
The German version of the MIDAS presented in this
study is a short, 7 item condition-specific questionnaire
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assessing disability due to migraine and headache, the
number of headache days in the last 3 months and pain
intensity (NRS 0–10). Although the phrasing of the
questionnaire is challenging, it is a practical instrument
for an assessment of headache related disability, which
in general takes less than 5 min to fill out and can be
obtained free of charge. The translation process was
challenged by the comprehensibility of the question-
naire. The German version of the MIDAS is a highly re-
liable instrument for assessing headache related
disability with a moderate internal consistency. Provided
validity testing is successful, the MIDAS can be recom-
mended for use in clinical practice as well as in research.
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Additional file 1: German version of the MIDAS questionnaire (final
version). Final German version of the MIDAS questionnaire. (DOCX 14 kb)
Abbreviatons
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